These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37121865)

  • 1. Impact of
    Andriole GL; Scarsbrook AF; Savir-Baruch B;
    Urol Oncol; 2023 Jun; 41(6):293.e1-293.e7. PubMed ID: 37121865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
    Kim EH; Siegel BA; Teoh EJ; Andriole GL;
    Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hormonal therapy on
    Bulbul JE; Hashem A; Grybowski D; Joyce C; Rashad E; Gabriel MS; Wagner RH; Savir-Baruch B
    Urol Oncol; 2022 Aug; 40(8):379.e9-379.e16. PubMed ID: 35738974
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Solanki AA; Savir-Baruch B; Liauw SL; Michalski J; Tward JD; Vapiwala N; Teoh EJ;
    Pract Radiat Oncol; 2020; 10(5):354-362. PubMed ID: 32464368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of
    Scarsbrook AF; Bottomley D; Teoh EJ; Bradley KM; Payne H; Afaq A; Bomanji J; van As N; Chua S; Hoskin P; Chambers A; Cook GJ; Warbey VS; Han S; Leung HY; Chau A; Miller MP; Gleeson FV;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):316-324. PubMed ID: 32068113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy.
    Payne H; Bomanji J; Bottomley D; Scarsbrook AF; Teoh EJ;
    Nucl Med Commun; 2022 Feb; 43(2):201-211. PubMed ID: 34669678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer.
    Bach-Gansmo T; Korsan K; Bogsrud TV
    Tomography; 2022 Jun; 8(3):1477-1484. PubMed ID: 35736868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world evidence of
    Friedrich NA; Gu L; Waller J; De Hoedt AM; Klaassen Z; Freedland SJ
    Prostate; 2024 Oct; 84(14):1336-1343. PubMed ID: 39031050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of
    Galgano SJ; McDonald AM; Rais-Bahrami S; Porter KK; Choudhary G; Burgan C; Bhambhvani P; Nix JW; Morgan DE; Li Y; Thomas JV; McConathy J
    AJR Am J Roentgenol; 2021 Sep; 217(3):720-729. PubMed ID: 33052718
    [No Abstract]   [Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
    Andriole GL; Kostakoglu L; Chau A; Duan F; Mahmood U; Mankoff DA; Schuster DM; Siegel BA;
    J Urol; 2019 Feb; 201(2):322-331. PubMed ID: 30179618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positivity Rate of [
    Bulbul JE; Grybowski D; Lovrec P; Solanki AA; Gabriel MS; Wagner RH; Savir-Baruch B
    Mol Imaging Biol; 2022 Feb; 24(1):42-49. PubMed ID: 34480289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by
    Devos G; Witters M; Moris L; Van den Broeck T; Berghen C; Devlies W; De Meerleer G; Goffin K; Jentjens S; Albersen M; Van Poppel H; Everaerts W; Joniau S
    World J Urol; 2021 Feb; 39(2):399-406. PubMed ID: 32417995
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Calais J; Ceci F; Eiber M; Hope TA; Hofman MS; Rischpler C; Bach-Gansmo T; Nanni C; Savir-Baruch B; Elashoff D; Grogan T; Dahlbom M; Slavik R; Gartmann J; Nguyen K; Lok V; Jadvar H; Kishan AU; Rettig MB; Reiter RE; Fendler WP; Czernin J
    Lancet Oncol; 2019 Sep; 20(9):1286-1294. PubMed ID: 31375469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage Therapies After 18F-Fluciclovine Detected Prostate Cancer Recurrences.
    Hwang L; Paluch J; Jadvar H; England JR; Desai B; Ballas LK
    Clin Nucl Med; 2020 Sep; 45(9):668-671. PubMed ID: 32520496
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ilhan H; Kroenke M; Wurzer A; Unterrainer M; Heck M; Belka C; Knorr K; Langbein T; Rauscher I; Schmidt-Hegemann NS; Schiller K; Bartenstein P; Wester HJ; Eiber M
    J Nucl Med; 2022 Aug; 63(8):1208-1214. PubMed ID: 35273094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management Impact of Metachronous Oligometastatic Disease Identified on
    Anderson RC; Velez EM; Jadvar H
    Mol Imaging Biol; 2022 Dec; 24(6):920-927. PubMed ID: 35604526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on
    Abiodun-Ojo OA; Jani AB; Akintayo AA; Akin-Akintayo OO; Odewole OA; Tade FI; Joshi SS; Master VA; Fielder B; Halkar RK; Zhang C; Goyal S; Goodman MM; Schuster DM
    J Nucl Med; 2021 Aug; 62(8):1089-1096. PubMed ID: 33517323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flare on [
    Malaspina S; Ettala O; Tolvanen T; Rajander J; Eskola O; Boström PJ; Kemppainen J
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):613-621. PubMed ID: 36161511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Management After
    Ng M; Guerrieri M; Wong LM; Taubman K; Sutherland T; Benson A; Byrne G; Koschel S; Yap K; Starmans M; Ong G; Macleod C; Foo M; Chao M
    J Nucl Med; 2022 Sep; 63(9):1343-1348. PubMed ID: 35058320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.